Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Live Conference Coverage of AACR 2020 Annual Virtual Meeting; April 27-28, 2020

Reporter: Stephen J. Williams, Ph.D.

The American Association for Cancer Research (AACR) will hold its Annual Meeting as a Virtual Online Format.  Registration is free and open to all, including non members.  Please go to

https://www.aacr.org/meeting/aacr-annual-meeting-2020/aacr-virtual-annual-meeting-i/?utm_source=Salesforce%20Marketing%20Cloud&utm_medium=Email&utm_campaign=&sfmc_s=0031I00000WsBJxQAN

to register for this two day meeting.  Another two day session will be held in June 2020 and will focus more on basic cancer research.

Please follow @pharma_BI who will be live Tweeting Real Time Notes from this meeting using the hashtag

#AACR20

And @StephenJWillia2

The following is a brief summary of the schedule.  Please register and go to AACR for detailed information on individual sessions.

 

AACR VIRTUAL ANNUAL MEETING I: SCHEDULE AT A GLANCE

AACR Virtual Annual Meeting I is available free Register Now

VIRTUAL MEETING I: BROWSER REQUIREMENTS AND ACCESSVIRTUAL MEETING I: FAQVIRTUAL MEETING I: MEETING PLANNER (ABSTRACT TITLES)

Presentation titles are available through the online meeting planner. The program also includes six virtual poster sessions consisting of brief slide videos. Poster sessions will not be presented live but will be available for viewing on demand. Poster session topics are as follows:

• Phase I Clinical Trials
• Phase II Clinical Trials
• Phase III Clinical Trials
• Phase I Trials in Progress
• Phase II Trials in Progress
• Phase III Trials in Progress

Schedule updated April 24, 2020

MONDAY, APRIL 27

Channel 1		Channel 2		Channel 3
9:00 a.m.-9:30 a.m. Opening Session _______________________
9:30 a.m.-11:40 a.m. Opening Clinical Plenary _______________________
11:40 a.m.-2:00 p.m. Clinical Plenary: Immunotherapy Clinical Trials 1 _______________________	___	11:45 a.m.-1:30 p.m. Minisymposium: Emerging Signaling Vulnerabilities in Cancer _______________________	___	11:45 a.m.-1:15 p.m. Minisymposium: Advances in Cancer Drug Design and Discovery __________________________
2:00 p.m.-4:50 p.m. Clinical Plenary: Lung Cancer Targeted Therapy _______________________	___	1:55 p.m.-4:15 p.m. Clinical Plenary: Breast Cancer Therapy _______________________	___	1:30 p.m.-3:30 p.m. Minisymposium: Drugging Undrugged Cancer Targets __________________________
4:50 p.m.-6:05 p.m. Symposium: New Drugs on the Horizon 1_______________________	___	4:50 p.m.-5:50 p.m. Minisymposium: Therapeutic Modification of the Tumor Microenvironment or Microbiome _______________________	___	4:00 p.m.-6:00 p.m. Minisymposium: Advancing Cancer Research Through An International Cancer Registry: AACR Project GENIE Use Cases__________________________

All session times are EDT.

TUESDAY, APRIL 28

Channel 1		Channel 2		Channel 3
9:00 a.m.-101:00 a.m. Clinical Plenary: COVID-19 and Cancer __________________________
11:00 a.m.-1:35 p.m. Clinical Plenary: Adoptive Cell Transfer Therapy__________________________	___	10:45 a.m.-12:30 p.m. Symposium: New Drugs on the Horizon 2_________________________	___	10:45 a.m.-12:30 p.m. Minisymposium: Translational Prevention Studies ______________________
	___	12:30 p.m.-1:25 p.m. Symposium: New Drugs on the Horizon 3 _________________________	___	12:30 p.m.-2:15 p.m. Minisymposium: Non-coding RNAs in Cancer ______________________
1:35 p.m.-3:35 p.m. Clinical Plenary: Early Detection and ctDNA__________________________	___	1:30 p.m.-3:50 p.m. Clinical Plenary: Immunotherapy Clinical Trials 2 _________________________	___	2:15 p.m.-3:45 p.m. Minisymposium: Novel Targets and Therapies______________________
3:35 p.m.-5:50 p.m. Minisymposium: Predictive Biomarkers for Immunotherapeutics__________________________	___	3:50 p.m.-5:35 p.m. Minisymposium: Evaluating Cancer Genomics from Normal Tissues through Evolution to Metastatic Disease _________________________	___	4:00 p.m.-4:55 p.m. Clinical Plenary: Targeted Therapy______________________
				5:00 p.m.-5:45 p.m. Symposium: NCI Activities– COVID-19 and Cancer Research Dinah Singer, NCI ______________________
				5:45 p.m.-6:00 p.m. Closing Session ______________________

All session times are EDT.

 

 

 

Day

• Monday, April 27, 2020
• Tuesday, April 28, 2020

 

Session Type

• Virtual Opening Session
• Virtual Clinical Plenary Session
• Virtual Symposium
• Virtual Minisymposium
• Virtual Poster Session
• Virtual Closing Session

Topic Tracks

• Bioinformatics and Systems Biology
• Cancer Chemistry
• Clinical Research Excluding Trials
• Clinical Trials
• Drug Development
• Experimental and Molecular Therapeutics
• Immunology
• Molecular and Cellular Biology/Genetics
• Prevention Research
• Science Policy
• Tumor Biology

For more on @pharma_BI and LPBI Group Conference Coverage in Real Time please go to

https://pharmaceuticalintelligence.com/press-coverage/

and

• Part One: The Process of Real Time Coverage using Social Media

• Part Two: List of BioTech Conferences 2013 to Present

• Part Three: Conference eProceedings DELIVERABLES & Social Media Analytics